Literature DB >> 20847766

In vivo validation of free-space fluorescence tomography using nuclear imaging.

Anikitos Garofalakis1, Albertine Dubois, Bertrand Kuhnast, Daniel M Dupont, Isabelle Janssens, Nicolas Mackiewicz, Frédéric Dollé, Bertrand Tavitian, Frédéric Ducongé.   

Abstract

The performance of small animal photonic imaging has been considerably improved since the development of fluorescence diffuse optical tomography (fDOT), which can reconstruct fluorescent probe distribution inside tissue. However, the quantification capabilities of this new technology are still a topic of debate, especially in comparison to classical nuclear imaging techniques. Here, we present a method to in vivo calibrate the quantity and localization of a probe provided by free-space fDOT (where no plate is compressing the mouse) with positron emission tomography (PET) and x-ray computed tomography, respectively. This methodology allowed us to demonstrate a strong linear correlation (R(2)=0.95) between fDOT and PET for probe concentrations ranging from 3 nM to 1 μM in a deep-seated organ.

Entities:  

Mesh:

Year:  2010        PMID: 20847766     DOI: 10.1364/OL.35.003024

Source DB:  PubMed          Journal:  Opt Lett        ISSN: 0146-9592            Impact factor:   3.776


  7 in total

1.  Noninvasive and quantitative assessment of in vivo angiogenesis using RGD-based fluorescence imaging of subcutaneous sponges.

Authors:  Michelle Keramidas; Véronique Josserand; Jean-Jacques Feige; Jean-Luc Coll
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

2.  From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors.

Authors:  Agnes Cibiel; Nam Nguyen Quang; Karine Gombert; Benoit Thézé; Anikitos Garofalakis; Frédéric Ducongé
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

3.  Fluorescence molecular tomography: principles and potential for pharmaceutical research.

Authors:  Florian Stuker; Jorge Ripoll; Markus Rudin
Journal:  Pharmaceutics       Date:  2011-04-26       Impact factor: 6.321

4.  Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography.

Authors:  Felix Gremse; Benjamin Theek; Sijumon Kunjachan; Wiltrud Lederle; Alessa Pardo; Stefan Barth; Twan Lammers; Uwe Naumann; Fabian Kiessling
Journal:  Theranostics       Date:  2014-07-26       Impact factor: 11.556

5.  In Vivo Follow-up of Brain Tumor Growth via Bioluminescence Imaging and Fluorescence Tomography.

Authors:  Coralie Genevois; Hugues Loiseau; Franck Couillaud
Journal:  Int J Mol Sci       Date:  2016-10-31       Impact factor: 5.923

6.  Co-registration of glucose metabolism with positron emission tomography and vascularity with fluorescent diffuse optical tomography in mouse tumors.

Authors:  Xiao Tong; Anikitos Garofalakis; Albertine Dubois; Raphaël Boisgard; Frédéric Ducongé; Régine Trébossen; Bertrand Tavitian
Journal:  EJNMMI Res       Date:  2012-05-07       Impact factor: 3.138

7.  Fusion of [(18)F]FDG PET with fluorescence diffuse optical tomography to improve validation of probes and tumor imaging.

Authors:  Anikitos Garofalakis; Albertine Dubois; Benoît Thézé; Bertrand Czarny; Bertrand Tavitian; Frédéric Ducongé
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.